Onderneming MedX Health Corp. Toronto S.E.
Aandelen
MDX
CA5850901037
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Phototherapeutic Lasers
64,4
%
| 0 | 48,7 % | 0 | 64,4 % | +18,00% |
SIAscopy
35,6
%
| 0 | 51,3 % | 0 | 35,6 % | -37,92% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
66,0
%
| 0 | 38,0 % | 0 | 66,0 % | +55,14% |
Europe
19,0
%
| 0 | 42,0 % | 0 | 19,0 % | -59,59% |
United States
9,0
%
| 0 | 14,0 % | 0 | 9,0 % | -42,58% |
Rest of World
6,0
%
| 0 | 6,0 % | 0 | 6,0 % | -10,68% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Lockyer
CEO | Chief Executive Officer | - | 25-04-23 |
Director of Finance/CFO | - | 29-04-22 | |
Bill Mitoulas
IRC | Investor Relations Contact | - | - |
Jeffrey Morris
SAM | Sales & Marketing | - | 01/11 |
Tarek El Hoss
SAM | Sales & Marketing | - | 02-08-22 |
Chantal Ward
PRN | Corporate Officer/Principal | - | - |
Mike Druhan
PRN | Corporate Officer/Principal | - | 09-09-20 |
Paul Karam
PRN | Corporate Officer/Principal | - | - |
Larry Petersen
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hennigar
BRD | Director/Board Member | 84 | 19-11-01 |
Kenneth McKay
CHM | Chairman | - | 19-11-01 |
Stephen Lockyer
CEO | Chief Executive Officer | - | 25-04-23 |
Ed Ho
BRD | Director/Board Member | - | 25-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 269 456 602 | 252 675 606 ( 93,77 %) | 0 | 93,77 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,57% | 212 mld. | |
+8,61% | 186 mld. | |
+26,34% | 151 mld. | |
+33,90% | 114 mld. | |
+2,17% | 65,57 mld. | |
+14,50% | 52,61 mld. | |
-3,30% | 46,8 mld. | |
-3,98% | 38,95 mld. | |
+6,66% | 37,64 mld. |